Gene: CCDC91
Official Full Name: coiled-coil domain containing 91provided by HGNC
Gene Summary: Predicted to enable identical protein binding activity. Involved in Golgi to lysosome transport. Located in nucleoplasm and trans-Golgi network. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20944 | CCDC91 Knockout cell line (HeLa) | Human | CCDC91 | 1:3~1:6 | Negative | Online Inquiry |
KO20945 | CCDC91 Knockout cell line (HCT 116) | Human | CCDC91 | 1:2~1:4 | Negative | Online Inquiry |
KO20946 | CCDC91 Knockout cell line (HEK293) | Human | CCDC91 | 1:3~1:6 | Negative | Online Inquiry |
KO20947 | CCDC91 Knockout cell line (A549) | Human | CCDC91 | 1:3~1:4 | Negative | Online Inquiry |
CCDC91 Gene Knockout Cell Lines are genetically engineered cell models that have undergone targeted gene disruption of the CCDC91 gene, known to play a pivotal role in various cellular processes, including cilia formation and intracellular transport mechanisms. These knockout cell lines provide a crucial tool for researchers studying the functional role of CCDC91 in cellular dynamics and its implications in human diseases, particularly those associated with cilia-related dysfunctions, such as ciliopathies.
The key function of these cell lines lies in their ability to mimic the loss-of-function mutations that may occur in organisms, allowing scientists to investigate the specific phenotypic changes and molecular pathways affected by the absence of CCDC91. By analyzing these changes, researchers can elucidate the gene's role in critical cellular processes, facilitating deeper insights into pathophysiological conditions and potential therapeutic targets.
The scientific importance of CCDC91 Gene Knockout Cell Lines extends across both fundamental and clinical research domains. They serve as indispensable resources for drug discovery, genetic studies, and elucidation of disease mechanisms. In clinical studies, these cell lines support preclinical investigations aimed at understanding drug efficacy or genetic predisposition to diseases linked with cilia impairment.
One of the standout advantages of our CCDC91 Gene Knockout Cell Lines is their validated genetic modification and characterized phenotypic traits, which offer enhanced reproducibility and reliability compared to similar products on the market. Our commitment to quality ensures that researchers can trust the integrity of their data, paving the way for more robust scientific conclusions.
This product holds exceptional value for researchers and clinicians alike, as it facilitates the exploration of complex biological questions, accelerates the drug development process, and furthers the understanding of genetic contributions to human health. By utilizing our expertly designed CCDC91 Gene Knockout Cell Lines, users can advance their research endeavors with confidence.
Our company prides itself on its extensive expertise in developing biological products tailored to the precise needs of the scientific community, ensuring that our offerings continually support cutting-edge research and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.